Disc Medicine annual operating expenses
2020
2021
2022
2023
2024
2025
Disc Medicine Operating Expenses Growth & History (IRON)
Disc Medicine's operating expenses was $236.0M for fiscal 2025.
View full Disc Medicine company overviewDisc Medicine annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $236.0M | $106.3M | +81.95% |
| 2024 | 2024-12-31 | $129.7M | $38.6M | +42.35% |
| 2023 | 2023-12-31 | $91.1M | $43.6M | +91.94% |
| 2022 | 2022-12-31 | $47.5M | $16.5M | +53.48% |
| 2021 | 2021-12-31 | $30.9M | −$3.1M | −9.13% |
| 2020 | 2020-12-31 | $34.0M | — | — |
Disc Medicine quarterly operating expenses
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $65.1M | $3.7M | +5.97% |
| Q1 2026 | 2026-03-31 | $69.5M | $29.6M | +74.04% |
| Q4 2025 | 2025-12-31 | $67.0M | $32.4M | +93.84% |
| Q3 2025 | 2025-09-30 | $67.7M | $34.8M | +106.04% |
| Q2 2025 | 2025-06-30 | $61.4M | $30.6M | +99.05% |
| Q1 2025 | 2025-03-31 | $39.9M | $8.5M | +26.97% |
| Q4 2024 | 2024-12-31 | $34.5M | $4.8M | +16.28% |
| Q3 2024 | 2024-09-30 | $32.9M | $13.9M | +73.31% |
| Q2 2024 | 2024-06-30 | $30.9M | $13.5M | +78.05% |
| Q1 2024 | 2024-03-31 | $31.5M | $6.3M | +25.22% |
| Q4 2023 | 2023-12-31 | $29.7M | $14.7M | +97.82% |
| Q3 2023 | 2023-09-30 | $19.0M | $8.5M | +80.91% |
| Q2 2023 | 2023-06-30 | $17.3M | $5.3M | +44.22% |
| Q1 2023 | 2023-03-31 | $25.1M | $15.2M | +152.26% |
| Q4 2022 | 2022-12-31 | $15.0M | — | — |
| Q3 2022 | 2022-09-30 | $10.5M | −$8.0M | −43.20% |
| Q2 2022 | 2022-06-30 | $12.0M | −$4.3M | −26.38% |
| Q1 2022 | 2022-03-31 | $10.0M | −$6.5M | −39.60% |
| Q3 2021 | 2021-09-30 | $18.4M | $10.5M | +132.10% |
| Q2 2021 | 2021-06-30 | $16.3M | $9.7M | +144.82% |
| Q1 2021 | 2021-03-31 | $16.5M | $6.9M | +71.22% |
| Q4 2020 | 2020-12-31 | $9.8M | — | — |
| Q3 2020 | 2020-09-30 | $7.9M | — | — |
| Q2 2020 | 2020-06-30 | $6.7M | — | — |
| Q1 2020 | 2020-03-31 | $9.6M | — | — |
Disc Medicine operating expenses trends
Over the last five fiscal years, Disc Medicine's operating expenses increased from $34.0M to $236.0M, a change of $202.0M. The latest reported quarter, Q2 2026, shows $65.1M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Disc Medicine source filings ↗